Zydus receives final approval from the USFDA for Ketorolac Tromethamine Tablets

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to market Ketorolac Tromethamine Tablets USP, 10 mg.

Related Keywords

Ahmedabad ,Gujarat ,India ,United States , ,Zydus Lifesciences ,Drug Administration ,Cadila Healthcare ,Ketorolac Tromethamine ,Lifesciences Limited ,Cadila Healthcare Limited ,United States Food ,Ketorolac Tromethamine Tablets ,Tromethamine Tablets ,Zydus ,Lifesciences ,Ine010b01027 ,Usfda ,Finalapproval ,Ketorolactromethaminetablets ,